Effect of Okinawa Propolis on PAK1 Activity ... - ACS Publications

Subscriber access provided by United Arab Emirates University | Libraries Deanship

Article

Effect of Okinawa Propolis on PAK1 activity, Caenorhabditis elegans Longevity, Melanogenesis, and Growth of Cancer Cells Nozomi Taira, Binh Cao Quan Nguyen, Pham Thi Be Tu, and Shinkichi Tawata J. Agric. Food Chem., Just Accepted Manuscript • DOI: 10.1021/acs.jafc.6b01785 • Publication Date (Web): 23 Jun 2016 Downloaded from http://pubs.acs.org on June 23, 2016

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a free service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are accessible to all readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

Journal of Agricultural and Food Chemistry is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 29

Journal of Agricultural and Food Chemistry

Effect of Okinawa Propolis on PAK1 activity, Caenorhabditis elegans Longevity, Melanogenesis, and Growth of Cancer Cells

Nozomi Taira,1 Binh Cao Quan Nguyen,1 Pham Thi Be Tu,1 and Shinkichi Tawata2,*

1

Department of Bioscience and Biotechnology, The United Graduate School of Agricultural

Sciences, Kagoshima University, Kagoshima 890-0065, Japan 2

Department of Bioscience and Biotechnology, Faculty of Agriculture, University of the

Ryukyus, Senbaru 1, Nishihara-cho, Okinawa 903-0213, Japan

*

Corresponding author: (S.T.) Tel: +81-98-895-8803. Fax: +81-98-895-8734.

E-mail: [email protected].

1

ACS Paragon Plus Environment


1

ABSTRACT: Propolis from different areas has been reported to inhibit oncogenic/ageing

2

kinase PAK1, which is responsible for a variety of conditions, including cancer, longevity and

3

melanogenesis. Here, crude extract of Okinawa propolis (OP) was tested against PAK1

4

activity, Caenorhabditis elegans (C. elegans) longevity, melanogenesis, and growth of cancer

5

cells. We found that OP blocks PAK1 and exhibits anti-cancer activity in A549 cell (human

6

lung cancer cell) line with IC50 values of 6 µg/mL and 12 µg/mL, respectively. Most

7

interestingly, OP (1 µg/mL) significantly reduces reproduction and prolongs the lifespan of C.

8

elegans by activating HSP-16.2 gene, as shown in the PAK1-deficient strain. Furthermore, OP

9

inhibits melanogenesis in a melanoma cell line (B16F10), by downregulating intracellular

10

tyrosinase activity with an IC50 of 30 µg/mL. Our results suggest that OP demonstrated life

11

span extending effect C. elegans, anticancer and antimelanogenic effects via PAK1

12

inactivation, therefore, this can be a potent natural medicinal supplement against

13

PAK1-dependent diseases.

14 15

KEYWORDS: PAK1, Okinawa propolis, longevity, Caenorhabditis elegans, melanogenesis,

16

cancer

2


Page 2 of 29

Page 3 of 29

17


INTRODUCTION

18

A major oncogenic/ageing kinase, PAK1 [p21 (RAC/CDC42)-activated kinase 1], is

19

accountable for a number of conditions including cancer, type 2 diabetes, Alzheimer’s disease,

20

obesity, hypertension, and a number of inflammatory and infectious diseases.1 Furthermore,

21

biochemical and genetic studies published in the last decade, have proven the essential role of

22

PAK1 in the malignant transformation of normal cell induced by RAS.1–3 Recently, by using a

23

model organism (C. elegans), it has been demonstrated that downregulation of PAK1 leads to

24

extended healthy life span, increased stress-resistance, and reduced fertility.4 In addition,

25

genes involved in regulating lifespan were identified in this oranism.5–7 PAK1 is also

26

accountable for the growth and progression of over 70% malignancies in human including

27

neurofibromatosis, breast and prostate cancers, and RAS-induced pancreatic and colon

28

cancers.8,9

29

Propolis, collected from different parts of the plant and exudates by honeybees is a

30

natural antibiotic. It has been used to treat or alleviate several maladies in traditional medicine

31

since ancient Egyptian time. Previous studies have shown that propolis possesses anti-cancer,

32

anti-inflammatory and anti-oxidant activities.10–14 There is no information about the

33

toxicological profile of Okinawa propolis (OP). However, Brazilian, New Zealand, and

34

European propolis have been reported reasonably non-toxic, with a no-effect level in mouse.15

35

The vegetation at the site of propolis collection widely determine the ingredients present in it.

36

For example, caffeic acid phenethyl ester (CAPE) present in the propolis from New Zealand

37

(namely Bio30) is the major anti-cancer ingredient responsible for downregulating the

38

Rac-PAK1 signaling pathway.16 Green propolis (GP) from Brazil contains Artepillin C (ARC),

39

which blocks PAK1 and prevents the growth of lung cancer cells (A549 cell line).8 However,

40

propolis obtained from semi-tropical areas in the Pacific such as Okinawa, Taiwan, and

41

Hawaii is very unique, as it does not containing CAPE nor ARC, but a variety of 3



42

prenylflavonoids including nymphaeols, derived from a common origin plant, Macaranga

43

tanarius.17 Taiwan Propolis (TP) contains propolin G, which induce apoptosis in brain cancer

44

cells, and protect rat cortical neurons from oxidative stress.11 In the case of OP, nymphaeol-A

45

was found to be the major compound responsible for the inhibition of tumor-induced

46

angiogenesis in HUVEC cells.18 Other prenylflavonoids were also isolated from OP and

47

showed strong anti-oxidant, anti-bacterial, and anti-angiogenic activities.17–19 However, the

48

effects of OP on PAK1 activity and on longevity, melanogenesis, and cancer cell proliferation,

49

remain to be clarified.

50

In the present study, the effect of OP on PAK1 activity, C. elegans longevity,

51

melanogenesis and cancer cell proliferation were investigated. We describe the lifespan

52

extending effect in C. elegans, the anti-melanogenic effect in melanoma cells (B16F10), and

53

the anti-cancer effect against A549 lung cancer cells of OP.

54 55

MATERIALS AND METHODS

56

C. elegans. The wild-type strain N2 (var. Bristol), and the transgenic strain CL2070

57

(dvls) of C. elegans, together with the OP50 strain of Escherichia coli, were purchased from

58

the C. elegans Genomic Center (University of Minnesota). C. elegans PAK1-deficient mutant

59

(Strain RB689) was kindly donated by Dr. Sumino Yanase of Daito Bunka University (Tokyo,

60

Japan).

61

Chemicals and reagents. The human lung cancer cell (A549) line was purchased

62

from the Japanese Collection of Research Bioresources Cell Bank (Osaka, Japan). Murine

63

B16F10 melanoma cell line was purchased from the American Type Culture Collection

64

(Rockville, MD, USA). Dulbecco’s modified minimum essential medium (D-MEM),

65

3-isobutyl-1-methylxanthine (IBMX), Triton X-100, and fetal bovine serum (FBS) were

66

obtained from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). Anti-PAK1 antibody IgG 4


Page 4 of 29

Page 5 of 29


67

was from Cell Signaling Technology (Danvers, Massachusetts, USA). Resveratrol,

68

3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT), protein A-agarose

69

beads, and myelin basic protein (MBP) bovine were bought from Sigma-Aldrich (Saint Louis,

70

Missouri, USA). Kinase Glo reagent and adenosine triphosphate (ATP) were purchased from

71

Promega (Madison, Wisconsin, USA). (+)-5-Fluoro-2’-deoxyuridine (FUdR) was obtained

72

from Kanto Chemicals (Tokyo, Japan).

73

Extraction of Okinawa Propolis (OP). Propolis was supplied by the Okinawa Yoho

74

Bee-farm (Okinawa, Japan) on June 30, 2015. Dried propolis was grounded with sterilized

75

pestle and mortar. 50 mL of 100% ethanol was used for the extraction of one gram ground

76

propolis. The mixture was sonicated for 3 h (AS ONE, Tokyo, Japan), and shaken for 21 h at

77

25 °C (Bio-Shaker, BR-300LF, TAITEC CORPORATION, Tokyo, Japan). The suspension

78

was filtered using Whatman® cellulose filter paper, and the filtrate was subjected to several

79

rounds of centrifugation at 14,357 × g for 5 min. To obtain a yellow, dry, crude extract (320

80

mg, yield 32%) of OP, the clear supernatant was evaporated under reduced pressure. 250 mg

81

of crude extract was dissolved in 1 mL of 100% ethanol to prepare 25% tincture of OP. The

82

sample was stored at -20 °C for subsequent use. The sample was diluted in dimethyl sulfoxide

83

(DMSO) or ethanol to achieve appropriate final concentrations.

84

Liquid chromatography-mass spectrometry (LC-MS) analysis. The major

85

compounds in OP were determined as previously described.17 OP filtrate (5 µL of 100 µg/mL)

86

was measured using a Shimadzu LC-MS (LC-20AD XR, Shimadzu Co., Kyoto, Japan)

87

coupled with a UV-Vis detector (SPD-M20A, Shimadzu). The separation was achieved on a

88

COSMOSIL 5C18-AR-II (150 mm x 2 mm I.D.; Nacalai Tesque, Kyoto, Japan). The mobile

89

phase was 0.5% acetic acid (v/v) in water (solvent A) and acetonitrile (solvent B); the rate of

90

flow was 0.2 mL/min; and the samples were detected at 280 nm. The gradient elution was

91

done as follows: 0-30 min, isocratic conditions 80% B; 30-35 min, linear gradient 80-100% 5



92

B; and 35-40 min, linear gradient 100-50% B. All MS data were acquired in negative

93

ionization mode. Each compound was quantified based on the peak area and molecular weight

94

according to Kumazawa et al.,17. The three major components in OP were prenylflavonoids

95

called nymphaeol A, B, and C (Figure 1).

96

Assay for the anti-cancer activity of OP. Human lung cancer cells (A549) carrying

97

the oncogenic K-RAS mutant were seeded into 6-well plates (Iwaki, Tokyo, Japan) at a

98

density of 2 × 105 cells/well in 10% FBS supplemented D-MEM growth medium. After 24 h

99

pre-culture, various concentrations of OP (10, 20, and 40 µg/mL) were applied for another 72

100

h. Later on trypan blue staining was performed as previously described.20 Both dead (stained

101

in blue) and live cells were counted using a hemocytometer (OneCell, Hiroshima, Japan).

102

Anti-cancer activity of OP was evaluated by comparing the percentage of viable treated cells

103

in relation to the control (untreated) cells. The assay was performed in three independent

104

experiment in triplicate.

105

Assay for the anti-PAK1 activity of OP. “Macaroni-Western” kinase assay21 was

106

used to evaluate anti-PAK1 activity of OP. Briefly, A549 cells (2 × 105 cells/well) were

107

pre-cultured in D-MEM medium for 24 h, and treated with several concentrations (1, 5, and

108

10 µg/mL) of OP for another 24 h. Cells were then lysed in 500 µL of lysis buffer (50 mM

109

Tris-HCl, pH 7.5, 150 mM NaCl, and 1% Triton X-100), on ice for 30 min. Cell lysates were

110

centrifuged at 100 × g for 5 min at 4 °C and, for immunoprecipitation experiments, the

111

supernatants were incubated with 50 µL of dilution buffer alone (50 mM Tris-HCl, pH 7.5,

112

150 mM NaCl, 100 µg/mL BSA) or in the presence of anti-PAK1 IgG (1:50 dilution) for 1 h

113

at 4 °C. Samples were then incubated further at 4 °C for 1 h in the presence of 10 µL of

114

protein A-agarose with constant shaking using a rotary mixer (Nissin, Tokyo, Japan). After

115

centrifugation, the pellet (containing PAK1) was rinsed twice with 500 µL of washing buffer

116

(50 mM Tris-HCl, pH 7.5 and 150 mM NaCl). The immunoprecipitated (IP)-PAK1 pellet was 6


Page 6 of 29

Page 7 of 29


117

resuspended in 35 µL of kinase buffer containing 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 20

118

mM MgCl2, and 0.1 mg/mL BSA. The kinase reaction was carried out by adding 10 µL of 2

119

µM ATP in distilled water, and 5 µL of MBP substrate (1 mg/mL in distilled water). The

120

reaction was incubated for 1 h at 37 °C with constant agitation. An equal volume of kinase

121

Glo reagent (50 µL) was added to each well after incubation, and to stabilize the luminescent

122

signal the plate was further incubated for 30 min. The cleared supernatant was then

123

transferred to a 96-well plate for analysis. Luminescence was recorded by an MTP-880 Lab

124

microplate reader (Corona, Ibaraki, Japan) with an integration time of 0.5 s per well. PAK1

125

activity of OP was calculated as percentage relative to the control.

126

Assessment of HSP-16.2-dependent GFP expression. The strain of C. elegans used

127

in this study was CL2070, which carries the transgenic HSP-16.2-GFP fusion gene

128

(HSP-16.2::GFP) as previously described.4 The nematodes were grown in nematode growth

129

medium (NGM) agar plates and fed with E. coli (OP50) at 20 °C. About 30 adult worms (in

130

each group) were transferred to fresh NGM plates with OP (0.5, 1 and 5 µg/mL) and

131

incubated at 20 °C for 48 h. The worms were heat-shocked for 2 h at 35 °C and then

132

incubated for 4 h at 20 °C and allowed to recover; each group was then fixed with a drop (1

133

µL) of 0.5 M sodium azide for microscopic visualization. To measure the fluorescence,

134

photographs of the GFP transgenic worms were obtained using a KEYENCE BZ-X700

135

fluorescence microscope.

136

Brood size assay. Approximately 20 worms of wild-type (N2) and RB689 C. elegans

137

strains were synchronous cultured, and the L1 animals were then transferred at 20 °C onto

138

NGM agar plates, where E. coli (OP50) and OP (0.5-1 µg/mL) were applied. The number of

139

eggs were counted 10 h after the adults worms started laying eggs. The number of eggs per

140

mother was used to calculate the brood size, as previously described.4

141

Lifespan assay. The synchronized C. elegans eggs (60-100) were placed on fresh 7



142

NGM agar plates containing E. coli (OP50) and supplemented with OP (1 µg/mL) or

143

resveratrol (10 µg/mL). 400 µL of FUdR (0.5 mg/mL) was added to the agar plate after the

144

worms reached adulthood (Day 3) for the prevention of progeny production. Worms were fed

145

with OP50 every 2 days, and the number of the surviving nematodes was counted every day,

146

as previously described.4,22

147

Measurement of B16F10 cell viability. B16F10 melanoma cells were cultured in

148

D-MEM supplemented with 10% heat-inactivated FBS and 1% penicillin/streptomycin

149

(10,000 U/mL and 100 µg/mL, respectively), at 37 °C in a humidified atmosphere containing

150

5% CO2. Cell viability (or growth rate) was determined using trypan blue assay, as previously

151

described.21 Briefly, B16F10 cells (2 × 104 cells/well) were seeded onto a 24-well plate. After

152

24 h of preculture, various concentrations of OP (10, 20, and 40 µg/mL) were applied for 72 h

153

at 37 °C. Cells were then washed twice with phosphate buffer and harvested with Accutase®,

154

and the viable (not-stained) cell number were calculated by performing trypan blue exclusion

155

test.

156

Measurement of melanin content. Melanin content was assayed as previously

157

described.23 In short, B16F10 cells were plated in a 24-well plate at a density of 2 × 104

158

cells/well. After 24 h of prelature, the culture medium was changed with normal

159

(supplemented with 10% FBS) or serum-free medium, and cells were treated with several

160

concentration (5-40 µg/mL) of OP. After 1 h, IBMX (a melanogenic hormone; 100 µM),

161

which activates PAK1, was added to the medium and cells were incubated for another 72 h at

162

37 °C. Cells were dissolved in 500 µL NaOH (1 N) containing 10% DMSO after washing

163

with phosphate buffer. To promote melanin solubilization samples were incubated at 80 °C for

164

1 h. The optical density of the mixed homogenate was measured at 490 nm.

165

Measurement of intracellular tyrosinase activity. Tyrosinase activity was

166

determined as described,24 with slight modifications. B16F10 cells were seeded in a 24-well 8


Page 8 of 29

Page 9 of 29


167

plate at a density of 2 × 104 cells/well. After 24 h of pre-culture, the culture medium was

168

replaced by normal (containing 10% FBS) and serum-free medium, and supplemented with

169

varying OP concentrations (10-40 µg/mL). After 1 h, IBMX (100 µM) was added and

170

incubated at 37 °C for another 72 h. Cells were then washed with ice cold phosphate buffer

171

and lysed with phosphate buffer (pH 6.8) containing 1% Triton X-100 (500 µL/well). The

172

plates were frozen for 30 min at -80 °C. 100 µL of 1% L-DOPA was added to each well after

173

thawing and mixing. Following incubation for 2 h at 37 °C, the absorbance was measured at

174

490 nm.

175

Statistical analysis. Data are expressed as mean ± standard errors (SE). Statistical

176

comparisons were done by one-way ANOVA followed by Duncan’s multiple-range test. For C.

177

elegans lifespan, the Median Survival Time (MST) was analyzed using Kaplan-Meier survival

178

curves and log-rank test. Statistical analysis was conducted using SPSS (version 16.0,

179

Chicago, Illinois), and p < 0.05 was considered significant.

180 181

RESULTS AND DISCUSSION

182

Anti-cancer and anti-PAK1 activity of OP. Although both ARC-containing

183

Brazilian green propolis (GP) and CAPE-based propolis such as Bio30, block PAK1 and have

184

been used for the treatment of cancer and some other PAK1-dependent diseases, the

185

anti-cancer and anti-PAK1 activities of OP still remain to be clarified. Thus, we used A549

186

cell line (the human lung cancer cell) for testing anti-cancer and anti-PAK1 activities and

187

found that OP inhibited cell growth concentration-dependently with an IC50 of 12 µg/mL

188

(Table 1). This cancer cell line is important as PAK1 has been indicated as the Achilles’s heel

189

for over 70% human cancer cells, and for around 64% of squamous non-small cell lung

190

cancers (NSCLC).8,25,26 A549 cell growth is strongly depended on PAK1 and carry an

191

oncogenic Ki-RAS mutant.1 Thus, we tested the effect of OP against PAK1 in this NSCLC 9



192

cell line, using the Macaroni-Western kinase assay, which is an effective system for screening

193

potent and safe PAK1 blockers.21 As shown in Table 1, OP strongly inhibited PAK1 with an

194

IC50 of 6 µg/mL. Since the apparent anti-PAK1 activity of OP is stronger than the anti-cancer

195

activity in the same cell line, it is most likely that OP inhibits PAK1 directly, as reported in

196

New Zealand propolis and GP.8,9 However, further research is necessary to validate this

197

hypothesis. It has been reported that, New Zealand propolis and GP inhibit PAK1 through its

198

direct effect on PAK1 signaling by suppressing its autophosphorylation.8,9 In agreement with

199

this, OP might affect PAK1 signaling as we found stronger effect of OP on PAK1 using

200

Macaroni-Western kinase assay. As summarized in Table 1, OP appears to be the strongest

201

anti-PAK1 blocker compared to the other two propolis (IC50 of Bio30 = 60 µg/mL, and IC50

202

of GP > 150 µg/mL).8,21 Moreover, the OP anti-cancer activity was several fold more potent

203

than that of the ARC-based GP (IC50 = 100 µg/mL), but slightly less potent than that of the

204

CAPE-based Bio30 (IC50 = 8 µg/mL).21 The above quantitative data based on the standard

205

cancer cell line (A549) could be useful for the quality control of various propolis and other

206

PAK1-blocking herbal products present on the market.

207

Effect of OP on heat-shock (HSP-16.2) gene expression, and C. elegans

208

reproduction and lifespan. HSP-16.2 gene has been found to be inactivated by PAK1 in C.

209

elegans and it is among the key regulators of lifespan and stress/heat shock resistance, as it

210

serves as a stress-sensitive indicator to predict lifespan.4,27 Hence, in this study, we tested the

211

effect of OP on HSP-16.2::GFP expression. At 0.5-1 µg/mL, OP significantly upregulated

212

HSP-16.2::GFP expression by more than 31 ± 0.7%, compared to that of control (Figure 2).

213

The effect of OP was clearly stronger than that of the positive control resveratrol.

214

Both CAPE from New Zealand propolis (Bio30) and ARC from GP upregulated the

215

expression of the heat-shock protein HSP-16.2 in transgenic C. elegans CL2070, and

216

suppressed the PAK1-dependent reproduction in wild-type C. elegans.4 Thus, a further 10


Page 10 of 29

Page 11 of 29


217

investigation was carried out to test the influence of OP treatment on C. elegans brood size.

218

The brood size decreased by 19% and 52% at 0.5 and 1 µg/mL of OP, respectively, compared

219

with the control (Figure 3), while resveratrol (10 µg/mL), on the other hand, reduced the

220

brood size by only 33%. The brood size of PAK1-deficient strain (RM689) was smaller than

221

the wild-type (N2), confirming that PAK1 promotes reproduction, as previously described.4

222

The longevity of PAK1-deficient C. elegans mutant (RB689) was 60% higher than

223

the wild type,4 and PAK1-blockers such as CAPE and apigenin from Bio30, as well as a

224

PAK1-blocking leaf extract from the Okinawa plant called Alpinia zerumbet showed positive

225

effects on the lifespan of C. elegans.22,28–31 Thus, to determine the potential lifespan-extending

226

effect of OP, worms were treated with either OP (1 µg/mL) or resveratrol (10 µg/mL) (Figure

227

4). OP significantly increased the nematodes’ lifespan by 33% (24 ± 0.2 days) compared with

228

the control (18 ± 1.1 days), as measured by MST. Moreover, the lifespan extension observed

229

with OP was clearly better than that with resveratrol (22 ± 1 days). Taken together, our results

230

suggest that OP has a positive effect on the lifespan of C. elegans and this is achieved through

231

PAK1 inhibition. To the best of our knowledge, this is the first example in which the propolis

232

extract extends C. elegans lifespan at such a low dose.

233

Anti-melanogenic effects of OP. The inhibition of melanogenesis can be useful not

234

only for skin-whitening purposes, but also for the treatment of hyperpigmentation. In our

235

previous study, we have demonstrated that propolis Bio30 inhibited PAK1-dependent

236

melanogenesis.21 Tyrosinase is the key enzyme for melanin production and very recently we

237

have found that melanogenesis depends on PAK1 by more than 50%. As the OP inhibit PAK1

238

(Table 1), we hypothesized that it would also inhibit intracellular tyrosinase activity and

239

decrease melanin content of B16F10 cells. In the present study, we found that OP also has a

240

potent anti-melanogenic effect. As shown in Figures 5 and 6, OP had a strong

241

anti-melanogenic activity in B16F10 melanoma cells (IC50 of 37 µg/mL). 11



242

Furthermore as shown in Figure 7, OP downregulated the intracellular tyrosinase

243

with an IC50 of 30 µg/mL. All of these results demonstrate that OP efficiently inhibited

244

melanogenesis in B16F10 melanoma cells.

245

In conclusion, this is the first report showing that OP significantly prolongs the

246

lifespan of C. elegans, and inhibits melanogenesis and cancer cell growth by blocking the

247

oncogenic/ageing/melanogenic kinase PAK1. So far there are two major anti-cancerous

248

propolis extracts available on the market: CAPE-based propolis (Bio30), and ARC-based

249

Brazilian green propolis (GP).8 Our results clearly indicate that, like Bio30, OP would be

250

among the best healthcare products to promote longevity, and for the treatment or prevention

251

of different PAK1-dependent disorders such as cancer and hyperpigmentation.

252

Finally, it would be worth noting that further identification of the major

253

PAK1-blocking nymphaeols in OP could be useful for developing a new potent

254

PAK1-blocker(s) for both clinical and cosmetic uses.

12


Page 12 of 29

Page 13 of 29

255


ACKNOWLEDGEMENT

256

We are grateful to Drs. Hiroshi Maruta (PAK Research Center, Melbourne) and

257

Sumino Yanase (Daito-Bunka University, Saitama, Japan) for their critical reading of this

258

manuscript and technical expertise. Nematode strains (RB689 and CL2070) used in this work

259

were provided by the Caenorhabditis Genetics Center (University of Minnesota). We are also

260

grateful to the International Research Center, University of the Ryukyus, Okinawa, Japan for

261

providing the facilities for LC-MS and the fluorescence microscope.

13



262

REFERENCES

263

(1)

Maruta, H. Herbal therapeutics that block the oncogenic kinase PAK1: a practical

264

approach towards PAK1-dependent diseases and longevity. Phytother. Res. 2014, 28

265

(5), 656–672.

266

(2)

He, H.; Levitzki, A.; Zhu, H. J.; Walker, F.; Burgess, A.; Maruta, H. Platelet-derived

267

growth factor requires epidermal growth factor receptor to activate p21-activated

268

kinase family kinases. J. Biol. Chem. 2001, 276 (29), 26741–26744.

269

(3)

Huynh, N.; Liu, K. H.; Baldwin, G. S.; He, H. P21-activated kinase 1 stimulates colon

270

cancer cell growth and migration/invasion via ERK- and AKT-dependent pathways.

271

Biochim. Biophys. Acta - Mol. Cell Res. 2010, 1803 (9), 1106–1113.

272

(4)

Yanase, S. PAK1-deficiency/down-regulation reduces brood size, activates HSP16.2

273

gene and extends lifespan in Caenorhabditis elegans. Drug Discov. Ther. 2013, 7 (1),

274

29–35.

275

(5)

Mihaylova, V. T.; Borland, C. Z.; Manjarrez, L.; Stern, M. J.; Sun, H. The PTEN tumor

276

suppressor homolog in Caenorhabditis elegans regulates longevity and dauer formation

277

in an insulin receptor-like signaling pathway. Proc. Natl. Acad. Sci. U. S. A. 1999, 96

278

(13), 7427–7432.

279

280

(6)

Murphy, C. T.; McCarroll, S.; Bargmann, C. I.; Fraser, A.; Kamath, R. S.; Ahringer, J.; Li, H.; Kenyon, C. Genes that act downstream of DAF-16 to influence the lifespan of

14


Page 14 of 29

Page 15 of 29


Caenorhabditis elegans. Nature 2003, 424 (6946), 277–283.

281

282

(7)

chaperone dependent upon insulin-like signals. Aging Cell 2003, 2 (2), 131–139.

283

284

Walker, G. A.; Lithgow, G. J. Lifespan extension in C. elegans by a molecular

(8)

Demestre, M.; Messerli, S. M.; Celli, N.; Shahhossini, M.; Kluwe, L.; V. Mautner;

285

Maruta, H. CAPE (Caffeic Acid Phenethyl Ester)-based Propolis Extract (Bio 30)

286

Suppresses the Growth of Human Neurofibromatosis (NF) Tumor Xenografts in Mice.

287

Phyther. Res. 2009, 23 (2), 226–230.

288

(9)

Demestre, M.; Messerli, M.; Maruta, H. Artepillin C (ARC) in Brazilian Green

289

Propolis Selectively Blocks Oncogenic PAK1 Signaling and Suppresses the Growth of

290

NF Tumors in Mice. Phyther. Res. 2009, 23 (3), 423–427.

291

(10)

various geographic origins. Food Chem. 2004, 84 (3), 329–339.

292

293

Kumazawa, S.; Hamasaka, T.; Nakayama, T. Antioxidant activity of propolis of

(11)

Huang, W. J.; Huang, C. H.; Wu, C. L.; Lin, J. K.; Chen, Y. W.; Lin, C. L.; Chuang, S.

294

E.; Huang, C. Y.; Chen, C. N. Propolin G, a Prenylflavanone, Isolated from Taiwanese

295

Propolis, Induces Caspase-Dependent Apoptosis in Brain Cancer Cells. J. Agric. Food

296

Chem. 2007, 55 (18), 7366–7376.

297

(12)

Borges, K. S.; Brassesco, M. S.; Scrideli, C. A.; Soares, A. E. E.; Tone, L. G.

298

Antiproliferative effects of Tubi-bee propolis in glioblastoma cell lines. Genet. Mol.

299

Biol. 2011, 34 (2), 310–314. 15



300

(13)

Chen, C. N.; Weng, M. S.; Wu, C. L.; Lin, J. K. Comparison of Radical Scavenging

301

Activity, Cytotoxic Effects and Apoptosis Induction in Human Melanoma Cells by

302

Taiwanese Propolis from Different Sources. eCAM 2004, 1 (2), 175–185.

303

(14)

Machado, J. L.; Assunção, A. K. M.; da Silva, M. C. P.; Reis, A. S. dos; Costa, G. C.;

304

Arruda, D. de S.; Rocha, B. A.; Vaz, M. M. de O. L. L.; Paes, A. M. de A.; Guerra, R.

305

N. M.; et al. Brazilian Green Propolis: Anti-Inflammatory Property by an

306

Immunomodulatory Activity. eCAM 2012, 2012, Article ID 157652, 10 page.

307

(15)

(propolis). Food Chem. Toxicol. 1998, 36 (4), 347–363.

308

309

Burdock, G. A. Review of the biological properties and toxicity of bee propolis

(16)

Xu, J. W.; Ikeda, K.; Kobayakawa, A.; Ikami, T.; Kayano, Y.; Mitani, T.; Yamori, Y.

310

Downregulation of Rac1 activation by caffeic acid in aortic smooth muscle cells. Life

311

Sci. 2005, 76 (24), 2861–2872.

312

(17)

Kumazawa, S.; Murase, M.; Momose, N.; Fukumoto, S. Analysis of antioxidant

313

prenylflavonoids in different parts of Macaranga tanarius, the plant origin of Okinawan

314

propolis. Asian Pac. J. Trop. Med. 2014, 7 (1), 16–20.

315

(18)

Tsuchiya, I.; Hosoya, T.; Ushida, M.; Kunimasa, K.; Ohta, T.; Kumazawa, S.

316

Nymphaeol-A Isolated from Okinawan Propolis Suppresses Angiogenesis and Induces

317

Caspase-Dependent Apoptosis via Inactivation of Survival Signals. eCAM 2013, 2013,

318

Article ID 82245, 9 pages. 16


Page 16 of 29

Page 17 of 29

319


(19)

Kumazawa, S.; Ueda, R.; Hamasaka, T.; Fukumoto, S.; Fujimoto, T.; Nakayama, T.

320

Antioxidant prenylated flavonoids from propolis collected in Okinawa, Japan. J. Agric.

321

Food Chem. 2007, 55 (19), 7722–7725.

322

(20)

2002, 71, 2161–2170.

323

324

Wu, J.; Wu, Y.; Yang, B. B. Anticancer activity of Hemsleya amabilis extract. Life Sci.

(21)

Nguyen, B. C. Q.; Be Tu, P. T.; Tawata, S.; Maruta, H. Combination of

325

immunoprecipitation (IP)-ATP_Glo kinase assay and melanogenesis for the assessment

326

of potent and safe PAK1-blockers in cell culture. Drug Discov. Ther. 2015, 9 (4), 289–

327

295.

328

(22)

Upadhyay, A.; Chompoo, J.; Taira, N.; Fukuta, M.; Tawata, S. Significant

329

Longevity-Extending Effects of Alpinia zerumbet Leaf Extract on the Life Span of

330

Caenorhabditis elegans. Biosci Biotechnol Biochem 2013, 77 (2), 217–223.

331

(23)

Yoon, N. Y.; Eom, T. K.; Kim, M. M.; Kim, S. K. Inhibitory effect of phlorotannins

332

isolated from Ecklonia cava on mushroom tyrosinase activity and melanin formation in

333

mouse B16F10 melanoma cells. J. Agric. Food Chem. 2009, 57 (10), 4124–4129.

334

(24)

Gevensleben, H.; Göhring, U.-J.; Büttner, R.; Heukamp, L. C.; Kunz, G.; Dimpfl, T.;

335

Jackisch, C.; Ortmann, O.; Albert, U.-S.; Bender, R.; et al. Comparison of MammaPrint

336

and TargetPrint results with clinical parameters in German patients with early stage

337

breast cancer. Int. J. Mol. Med. 2010, 26 (6), 837–843. 17



338

(25)

Ong, C. C.; Jubb, A. M.; Haverty, P. M.; Zhou, W.; Tran, V.; Truong, T.; Turley, H.;

339

Koeppen, H.; Hoe, K. P. Targeting p21-activated kinase 1 (PAK1) to induce apoptosis

340

of tumor cells. PNAS 2011, 108 (17), 7177–7182.

341

(26)

Rettig, M.; Trinidad, K.; Pezeshkpour, G.; Frost, P.; Sharma, S.; Moatamed, F.;

342

Tamanoi, F.; Mortazavi, F. PAK1 kinase promotes cell motility and invasiveness

343

through CRK-II serine phosphorylation in non-small cell lung cancer cells. PLoS One

344

2012, 7 (7), e42012.

345

(27)

Rea, S. L.; Wu, D.; Cypser, J. R.; Vaupel, J. W.; Johnson, T. E. A stress-sensitive

346

reporter predicts longevity in isogenic populations of Caenorhabditis elegans. Nat.

347

Genet. 2005, 37 (8), 894–898.

348

(28)

Wilson, M. A.; Shukitt-Hale, B.; Kalt, W.; Ingram, D. K.; Joseph, J. A.; Wolkow, C. A.

349

Blueberry polyphenols increase lifespan and thermotolerance in Caenorhabditis elegans.

350

Aging Cell 2006, 5 (1), 59–68.

351

(29) Wiegant, F. A. C.; Surinova, S.; Ytsma, E.; Langelaar-Makkinje, M.; Wikman, G.; Post,

352

J. A. Plant adaptogens increase lifespan and stress resistance in C. elegans.

353

Biogerontology 2009, 10 (1), 27–42.

354

(30)

Liao, V. H. C.; Yu, C. W.; Chu, Y. J.; Li, W. H.; Hsieh, Y. C.; Wang, T. T.

355

Curcumin-mediated lifespan extension in Caenorhabditis elegans. Mech. Ageing Dev.

356

2011, 132 (10), 480–487. 18


Page 18 of 29

Page 19 of 29

357


(31)

Pietsch, K.; Saul, N.; Chakrabarti, S.; Stürzenbaum, S. R.; Menzel, R.; Steinberg, C. E.

358

W. Hormetins, antioxidants and prooxidants: defining quercetin-, caffeic acid- and

359

rosmarinic acid-mediated life extension in C. elegans. Biogerontology 2011, 12 (4),

360

329–347.

361

19



Figure captions Figure 1. HPLC profile and chemical structures of the main constituents of OP. (A) nymphaeol-B; (B) isonymphaeol-B; (C) nymphaeol-A; (D) 3’-geranyl-naringenin; (E) nymphaeol-C.

Figure 2. HSP-16.2 gene activation by OP of in C. elegans (CL2070). (A) Image of HSP-16.2::GFP expression in the control worms and worms treated with OP (1 µg/mL). (B) GFP intensities from for three experiments were quantified in each CL2070 group. Each value represents the mean ± SE of three independent determinations. Statistical differences between treatment and control are indicated by asterisks (p < 0.05 = *, p < 0.01 = **, p < 0.001 = ***).

Figure 3. Reduction in Brood size by OP. OP significantly reduced the number of eggs laid by wild-type nematodes. Resveratrol was used as positive control; RB689 is the PAK1-deficient strain. Each value represents the mean ± SE of three independent determinations. Statistical differences between the treatment and the control are indicated by asterisks (p < 0.05 = *, p < 0.01 = **, p < 0.001 = ***).

Figure 4. Effects of OP on C. elegans lifespan. (A) Survival curves of C.elegans, (B) Median survival time (MST) in worms. OP extended both the survival % and median survival time of C.elegans. Statistical differences between the treatment and the control was demonstrated by log-rank test using the Kaplan-Meier survival analysis (p < 0.05 = *, p < 0.01 = **, p < 0.001 = ***, n = 156).

Figure 5. OP has no effect on the viability of melanoma cells. The results are displayed as percentage of control samples (mean ± SE, of three independent experiment in triplicate). 20


Page 20 of 29

Page 21 of 29


Statistical differences between the treatment and the control are indicated by asterisks (p < 0.05 = *, p < 0.01 = **, p < 0.001 = ***).

Figure 6. Anti-melanogenic activity of OP in melanoma cells. The results are displayed as percentage of control samples (mean ± SE, of three independent experiment in triplicate). Statistical differences between the treatment and the control are indicated by asterisks (p < 0.05 = *, p < 0.01 = **, p < 0.001 = ***).

Figure 7. Downregulation of intracellular tyrosinase activity in melanoma cells by OP. The results are displayed as percentage of control samples (mean ± SE, of three independent experiment in triplicate). Statistical differences between the treatment and the control are indicated by asterisks (p < 0.05 = *, p < 0.01 = **, p < 0.001 = ***).

21



Page 22 of 29

Table 1. Anti-cancer and anti-PAK1 activity of different propolis products. IC50 value (µg/mL)

Propolis type

Anti-cancer activity

Okinawa propolis Green propolis

a

Anti-PAK1 activity

12

5

100

>150

a

a

Bio 30 8 60 These propolis have been reported to inhibit A549 cancer cell growth by inhibiting PAK1 directly (References 8 and 19 for Green propolis and Bio 30, respectively).

Figure 1.

22


Page 23 of 29


Figure 2.

23



Figure 3.

24


Page 24 of 29

Page 25 of 29


Figure 4.

25



Figure 5.

26


Page 26 of 29

Page 27 of 29


Figure 6.

27



Figure 7.

28


Page 28 of 29

Page 29 of 29


84x47mm (96 x 96 DPI)


Effect of Okinawa Propolis on PAK1 Activity ... - ACS Publications

Recommend Documents